This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


5eg9

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "5eg9" [edit=sysop:move=sysop])
Line 1: Line 1:
-
'''Unreleased structure'''
+
==The cap binding site of influenza virus protein PB2 as a drug target==
-
 
+
<StructureSection load='5eg9' size='340' side='right' caption='[[5eg9]], [[Resolution|resolution]] 2.30&Aring;' scene=''>
-
The entry 5eg9 is ON HOLD until Paper Publication
+
== Structural highlights ==
-
 
+
<table><tr><td colspan='2'>[[5eg9]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5EG9 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5EG9 FirstGlance]. <br>
-
Authors: Severin, C., Rocha de Moura, T., Liu, Y., Li, K., Zheng, X., Luo, M.
+
</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5eg7|5eg7]], [[5eg8|5eg8]]</td></tr>
-
 
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5eg9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5eg9 OCA], [http://pdbe.org/5eg9 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5eg9 RCSB], [http://www.ebi.ac.uk/pdbsum/5eg9 PDBsum]</span></td></tr>
-
Description: The cap binding site of influenza virus protein PB2 as a drug target
+
</table>
-
[[Category: Unreleased Structures]]
+
== Function ==
 +
[[http://www.uniprot.org/uniprot/PB2_I02A6 PB2_I02A6]] Plays an essential role in transcription initiation and cap-stealing mechanism, in which cellular capped pre-mRNAs are used to generate primers for viral transcription. Binds the cap of the target pre-RNA which is subsequently cleaved after 10-13 nucleotides by PA. Plays a role in the initiation of the viral genome replication and modulates the activity of the ribonucleoprotein (RNP) complex. In addition, participates in the inhibition of type I interferon induction through interaction with the host mitochondrial antiviral signaling protein MAVS.[UniProtKB:P03428]
 +
__TOC__
 +
</StructureSection>
[[Category: Li, K]]
[[Category: Li, K]]
-
[[Category: Luo, M]]
 
-
[[Category: Zheng, X]]
 
[[Category: Liu, Y]]
[[Category: Liu, Y]]
 +
[[Category: Luo, M]]
 +
[[Category: Moura, T Rocha de]]
[[Category: Severin, C]]
[[Category: Severin, C]]
-
[[Category: Rocha De Moura, T]]
+
[[Category: Zheng, X]]
 +
[[Category: Pb2 cap]]
 +
[[Category: Viral protein]]

Revision as of 17:27, 10 February 2016

The cap binding site of influenza virus protein PB2 as a drug target

5eg9, resolution 2.30Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/5eg9"
Personal tools